ASTROGEN
ASTROGEN
Industry:
Biotechnology Pharmaceutical Product Research
Founded:
2017-01-01
Address:
Daegu, Taegu-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.astrogen.co.kr
Total Employee:
11+
Status:
Active
Contact:
+82 053 254 8850
Total Funding:
22 B KRW
Technology used in webpage:
Euro CrUX Top 50m CrUX Dataset Pound Sterling Japanese Yen
Similar Organizations
AlphaNavi Pharma
AlphaNavi Pharma specializes in the research and development of new drugs.
Autotelic Bio
Autotelic Bio is a bio technology company that researches and develops anti-cancer drugs.
Boan Biotech
Boan Biotech is a biopharmaceutical company developing therapeutic antibodies.
Everna
Everna is a biotech company developing novel therapeutics.
Ticaros
Ticaros is a biotech company that develops immune anti-cancer drugs.
YZY Bio
YZY Bio is a biotechnology company that develops anti-tumor bispecific antibodies.
Investors List
BNK Venture Capital
BNK Venture Capital investment in Series B - Astrogen
Hi Investment Partners
Hi Investment Partners investment in Series B - Astrogen
KB Securities
KB Securities investment in Series B - Astrogen
Partners Investment
Partners Investment investment in Series B - Astrogen
Intops Investment
Intops Investment investment in Series B - Astrogen
WONIK Investment Partners
WONIK Investment Partners investment in Series B - Astrogen
IBK Securities
IBK Securities investment in Series B - Astrogen
Wooshin Venture Investment
Wooshin Venture Investment investment in Series B - Astrogen
Partners Investment
Partners Investment investment in Series B - Astrogen
KB Securities
KB Securities investment in Series B - Astrogen
Official Site Inspections
http://www.astrogen.co.kr
- Host name: 203.245.24.18
- IP address: 203.245.24.18
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Astrogen"
ASTROGEN
About the Company. Astrogen, inc. aims to develop and commercialize treatments for rare neurological disorders quickly based on clinical experience, allowing patients to take โฆSee details»
์์คํธ๋ก์
[๋ชจ์ง๋ด์ฉ] ๋ชจ์ง ๊ธฐ๊ฐ: 2025๋ 3์ 21์ผ(๊ธ) - 3์ 28์ผ(๊ธ) (18์๊น์ง) ๋ชจ์ง ๋์: ๋ฐ๋ฌ ์ฅ์ ์๋๊ณผ ํจ๊ปํ๊ณ ์ถ์ ๋๊ตฌ/๊ฒฝ๋ถ ๊ฑฐ์ฃผ ์ฑ์ธ(๋จ๋ ๋ฌด๊ด) *๊ด๋ จ ํ๊ณผ์(ํน์ ๊ต์ก๊ณผ, ์ฌํ๋ณต์งํ๊ณผ ๋ฑ) ๋ฐ ์ ์ฌ ๊ฒฝํ์ ์ฐ๋ ๋ชจ์ง ์ธ์: ์ด 8๋ช (์ฑ์ธ โฆSee details»
Astrogen Co.,Ltd. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Astrogen Co.,Ltd. of Daegu, Daegu. Get the latest business insights from Dun & Bradstreet.See details»
Astrogen - Crunchbase Company Profile & Funding
Astrogen is a biotech company developing new drugs. AST-001: A drug in development aimed at treating core symptoms of Autism Spectrum Disorder in โฆSee details»
Astrogen Inc. - LinkedIn
Astrogen Inc. is a South Korea-based biopharmaceutical company specializing in the development of innovative small molecule therapies for neurological and rare diseases. โฆSee details»
Astrogen 2025 Company Profile: Valuation, Funding
When was Astrogen founded? Astrogen was founded in 2017. Where is Astrogen headquartered? Astrogen is headquartered in Daegu, South Korea. What is the size of Astrogen? Astrogen has 41 total employees. What industry is Astrogen โฆSee details»
Astrogen - Products, Competitors, Financials, Employees, โฆ
Astrogen.co.kr. Overview & Products; Financials; People; Founded Year 2017. Stage Corporate Minority | Alive. Total Raised $28.78M. Last Raised $1.54M | 1 yr ago. About Astrogen. โฆSee details»
Astrogen - Company Profile - Tracxn
Feb 25, 2025 Astrogen - Provider of drugs for neurological diseases. Raised a total funding of $23.7M over 3 rounds from 3 investors. ... Website: astrogen.co.kr; Phone Number: +82 ***** โฆSee details»
์ฃผ์ํ์ฌ ์์คํธ๋ก์ - ์ฌ์ ์๋ฑ๋ก๋ฒํธ์กฐํ
Astrogen Co.,Ltd. ๊ตญ์ธ์ฒญ์ฐ์ ๋ถ๋ฅ: ๋๋ถ๋ฅ : ์ ๋ฌธ, ๊ณผํ ๋ฐ ๊ธฐ์ ์๋น์ค์ . ์ค๋ถ๋ฅ : ์ฐ๊ตฌ๊ฐ๋ฐ์ . ์๋ถ๋ฅ : ์ธ๋ฌธ ๋ฐ ์ฌํ๊ณผํ ์ฐ๊ตฌ๊ฐ๋ฐ์ . ์ธ๋ถ๋ฅ : ์ธ๋ฌธ ๋ฐ ์ฌํ๊ณผํ ์ฐ๊ตฌ๊ฐ๋ฐ์ . ์ธ์ธ๋ถ๋ฅ : ๊ธฐํ โฆSee details»
Astrogen Co., Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Astrogen Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, Disease Domain:Nervous System Diseases, Endocrinology and Metabolic Disease, โฆSee details»
Astrogen - VentureRadar
Astrogen Co., Ltd. a clinical and research-oriented biotech company that develops innovative new drugs for intractable neurological diseases. VentureRadar Research / Company Website. โฆSee details»
Astrogen Co. Ltd - BioCentury Company Profiles - BCIQ
BioCentury-BayHelix East-West BioPharma Summit. BioCentury-BIA Jefferies UK 2023. The East-West Healthcare Reception 2024See details»
Astrogen Co., Ltd. (Astrogen Co., Ltd.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ โฆ
ไบ่งฃAstrogen Co., Ltd. (Astrogen Co., Ltd.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็4้กนไธดๅบ่ฏ้ช๏ผ็พ็ ้ขๅ:็ฅ็ป็ณป็ป็พ็ ๏ผๅ ๅๆณไธไปฃ่ฐข็พ็ ๏ผ่ฟ็ค๏ผๆๆฏๅนณๅฐ:ๅฐๅๅญๅ่ฏ๏ผ่ฏ โฆSee details»
Astrogen - Crunchbase Company Profile & Funding
Astrogen is a biotech company developing new drugs.See details»
Astrogen - Overview, News & Similar companies | ZoomInfo.com
View Astrogen (www.astrogen.co.kr) location , revenue, industry and description. Find related and similar companies as well as employees by title and much more. Products. Contact & โฆSee details»
Astrogen - BIO International Convention 2025
Astrogen was founded by a pediatric neurologist and develops treatments for neurological diseases based on small molecules. AST-001, the core pipeline, is a treatment for core โฆSee details»
Korean startup Astrogen raises $7.5 million for AI application
Jan 25, 2022 Astrogen Ltd., a Korean biotech startup that is developing new drugs for intractable neurological diseases, raised 9 billion won ($7.5 million) in Series B bridge funding, according โฆSee details»
StartUp_์ฃผ์ํ์ฌ ์์คํธ๋ก์ - NextRound
์ํ์คํํธ๋ผ ๋ฑ ๋์น์ฑ ์ ๊ฒฝ ์งํ์ ๊ฒฝ์ฐ ๊ทผ๋ณธ์ ์ธ ์น๋ฃ์ ๊ฐ ์ ์ธ๊ณ์ ์ผ๋ก ํฌ๊ทํฉ๋๋ค. ๋น์ฌ๋ ์์์ ์ฃผ๋ ์ ์ฝ๊ฐ๋ฐ, ์ธ๊ณต์ง๋ฅ ๊ธฐ๋ฐ ์ ์ฝํ๋ณด ๋ฌผ์ง ๋ฐ๊ตด, bbbํฌ๊ณผ ํ๋จ ์์คํ ๋ฑ ํต์ฌ ๋ ธํ์ฐ์ โฆSee details»
StartUp_์์คํธ๋ก์ - NextRound
์์ ๋ฐ ํดํ์ฑ ์ ๊ฒฝ์งํ ์น๋ฃ ํ๋ณด ๋ฌผ์ง ๊ฐ๋ฐ ์ค์ธ ์์๊ณผ ์ฐ๊ตฌ ์ค์ฌ ๋ฐ์ด์ค ํ์ฌ. ๋ฆฌ๋ ํ์ดํ๋ผ์ธ์ธ ast-001์ ์ํ์คํํธ๋ผ์ฅ์ ๋ฅผ ์ ์์ฆ์ผ๋ก '20๋ 7์์ ์์ฝ์ฒ ์น์ธ์ ๋ฐ์ '21๋ 2์๋ถํฐ ๊ตญ๋ด โฆSee details»
AST-035 - Drug Targets, Indications, Patents - Synapse
AST-035, Initially developed by Astrogen Co., Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Neoplasms,Nervous System Diseases,Other ...See details»